Synergy Disc
Synergy Spine Solutions, Inc. · Decision date Jul 6, 2026
What did the FDA decide?
FDA records P250028/S002 as a supplement to PMA P250028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 6, 2026.
FDA approval order statement
approval for automated polishing of the mirrored surfaces of the endplates as an alternate to manual polishing at Normal Noble
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Jul 6, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P250028/S002
- Regulatory pathway
- PMA supplement
- Applicant
- Synergy Spine Solutions, Inc.
- Product code
- MJO
- Decision code
- OK30
- Decision date
- Jul 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, intervertebral disc.
- Applicant
- Synergy Spine Solutions, Inc.
- Product code
- MJO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P250028. Subsequent supplements may change the device or its indications.
FDA decision timeline
P250028 · Original PMA
Synergy Disc
P250028/S001 · Related supplement
Synergy Disc
P250028/S002 received
Application receipt date recorded by FDA.
P250028/S002 · FDA decision
30-Day Notice
P250028/S003 · Related supplement
Synergy Disc
Timeline entries are records held by MedtechLedger for P250028. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P250028
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Synergy DiscP250028 | Synergy Spine Solutions, Inc. | PMA approval | Feb 26, 2026 | FDA |
Synergy DiscP250028/S001 | Synergy Spine Solutions, Inc. | PMA supplement | Apr 9, 2026 | FDA |
Synergy DiscP250028/S003 | Synergy Spine Solutions, Inc. | PMA supplement | Sep 17, 2026 | FDA |
Explore the linked device profile
Other records with product code MJO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BAGUERAC Cervical Disc ProsthesisP250042/S002 | Spineart USA, Inc. | PMA supplement | Sep 22, 2026 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
prodisc C NovaP070001/S031 | Centinel Spine, LLC | PMA supplement | Sep 9, 2026 | FDA |
BAGUERAC Cervical Disc ProsthesisP250042/S001 | Spineart USA, Inc. | PMA supplement | Aug 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Synergy Spine Solutions, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 357 S. Mccaslin Blvd., Suite 120, Louisville, CO, 80027
Sources and methodology
- Original FDA record: P250028/S002
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




